ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer

This study is ongoing, but not recruiting participants.
Study NCT00031837.   Last updated on October 18, 2008.   Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:
1 Conditions listed in this trial
Cancer-Related Problem/Condition
Pancreatic Cancer
2 Additional conditions recognized in this trial
Pancreatic Neoplasms
3 More general conditions related to this trial
Digestive System Diseases
Digestive System Neoplasms
Endocrine Gland Neoplasms
Endocrine System Diseases
Neoplasms
Neoplasms by Site
Pancreatic Diseases
4 Interventions listed in this trial
dalteparin
gemcitabine hydrochloride
quality-of-life assessment
5 Additional drug interventions recognized in this trial
Gemcitabine
6 More general drug interventions related to this trial
Anti-Infective Agents
Anticoagulants
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Antiviral Agents
Cardiovascular Agents
Enzyme Inhibitors
Fibrin Modulating Agents
Fibrinolytic Agents
Hematologic Agents
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Radiation-Sensitizing Agents
Therapeutic Uses
7 Sponsors listed in this trial
University of Rochester
National Cancer Institute (NCI)




Links to all studies - primarily for crawlers